Literature DB >> 10618509

Skin chamber technique for study of in vivo exudated human neutrophils.

P Follin1.   

Abstract

The development of new techniques for isolation of neutrophils extravasated in vivo have been essential for studying the dynamics of the inflammatory response in humans. Methods for generating inflammatory skin reactions were first presented in the mid 1950s, and later a skin blistering technique based on suction was introduced. With this procedure, small areas of denuded dermis, called "skin windows", are created and covered with special chambers containing a medium that attracts exudated neutrophils. By comparing the neutrophils collected in such chambers with those isolated from peripheral blood, it is possible to investigate the functional modifications that neutrophils undergo when attracted to an inflammatory process. The skin-blister chamber technique represents an aseptic, non-traumatic and reproducible model of inflammation that can be used to study in vivo activated human neutrophils. The background, methodological aspects and options of this technique are described, together with the functional characteristics of exudated neutrophils.

Entities:  

Mesh:

Year:  1999        PMID: 10618509     DOI: 10.1016/s0022-1759(99)00153-2

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  13 in total

1.  Editorial: will the real neutrophil please stand up?

Authors:  Kol A Zarember; Douglas B Kuhns
Journal:  J Leukoc Biol       Date:  2011-12       Impact factor: 4.962

Review 2.  Omega-3 fatty acids and stress-induced immune dysregulation: implications for wound healing.

Authors:  Janice K Kiecolt-Glaser; Ronald Glaser; Lisa M Christian
Journal:  Mil Med       Date:  2014-11       Impact factor: 1.437

3.  Newly recruited human monocytes have a preserved responsiveness towards bacterial peptides in terms of CD11b up-regulation and intracellular hydrogen peroxide production.

Authors:  E Dadfar; S H Jacobson; J Lundahl
Journal:  Clin Exp Immunol       Date:  2007-03-26       Impact factor: 4.330

4.  In vivo transmigrated monocytes from patients with stable coronary artery disease have a reduced expression of CD11b.

Authors:  J M Paulsson; E Dadfar; C Held; S H Jacobson; J Lundahl
Journal:  Clin Exp Immunol       Date:  2008-05-05       Impact factor: 4.330

5.  Regulation of neutrophil apoptosis differs after in vivo transmigration to skin chambers and synovial fluid: a role for inflammasome-dependent interleukin-1β release.

Authors:  Karin Christenson; Lena Björkman; Anna Karlsson; Johan Bylund
Journal:  J Innate Immun       Date:  2013-04-05       Impact factor: 7.349

6.  Drift-Diffusion Analysis of Neutrophil Migration during Inflammation Resolution in a Zebrafish Model.

Authors:  Geoffrey R Holmes; Giles Dixon; Sean R Anderson; Constantino Carlos Reyes-Aldasoro; Philip M Elks; Stephen A Billings; Moira K B Whyte; Visakan Kadirkamanathan; Stephen A Renshaw
Journal:  Adv Hematol       Date:  2012-07-29

Review 7.  Assessment of leukocyte trafficking in humans using the cantharidin blister model.

Authors:  William J Jenner; Derek W Gilroy
Journal:  JRSM Cardiovasc Dis       Date:  2012-04-05

8.  Novel translational model of resolving inflammation triggered by UV-killed E. coli.

Authors:  Madhur P Motwani; Julia D Flint; Roel Ph De Maeyer; James N Fullerton; Andrew M Smith; Daniel Jb Marks; Derek W Gilroy
Journal:  J Pathol Clin Res       Date:  2016-05-04

9.  Pivotal Advance: Pharmacological manipulation of inflammation resolution during spontaneously resolving tissue neutrophilia in the zebrafish.

Authors:  Catherine A Loynes; Jane S Martin; Anne Robertson; Daniel M I Trushell; Philip W Ingham; Moira K B Whyte; Stephen A Renshaw
Journal:  J Leukoc Biol       Date:  2010-02       Impact factor: 4.962

10.  The human neutrophil subsets defined by the presence or absence of OLFM4 both transmigrate into tissue in vivo and give rise to distinct NETs in vitro.

Authors:  Amanda Welin; Firoozeh Amirbeagi; Karin Christenson; Lena Björkman; Halla Björnsdottir; Huamei Forsman; Claes Dahlgren; Anna Karlsson; Johan Bylund
Journal:  PLoS One       Date:  2013-07-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.